EP Patent

EP0760651A1 — Pharmaceutical compositions derived from microelmulsion-based gels, method for their preparation and new microemulsion-based gels

Assigned to Bayer Oy · Expires 1997-03-12 · 29y expired

What this patent protects

The invention relates to a pharmaceutical composition comprising a microemulsion made up of a hydrophilic component, a lipophilic component, a surfactant and a drug, wherein the hydrophilic component, the lipophilic component and the surfactant form, when examined on a macroscopi…

USPTO Abstract

The invention relates to a pharmaceutical composition comprising a microemulsion made up of a hydrophilic component, a lipophilic component, a surfactant and a drug, wherein the hydrophilic component, the lipophilic component and the surfactant form, when examined on a macroscopic scale, a one-phase solution. The hydrophilic component is dispersed as colloidal droplets in the lipophilic component, or the lipophilic component is dispersed as colloidal droplets in the hydrophilic component. According to still another alternative the hydrophilic and the lipophilic components form a microemulsion with bicontinuous structure wherein said components form elongated adjacent channels. The drug is dissolved in the dispersed component or, in case of a microemulsion with a bicontinuous structure, in the hydrophilic or the lipophilic component. The microemulsion is stabilized by means of the surfactant. It is characteristic that a gelatinizer and water are added to the microemulsion thereby bringing the microemulsion into a gel form.

Drugs covered by this patent

Patent Metadata

Patent number
EP0760651A1
Jurisdiction
EP
Classification
Expires
1997-03-12
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Oy
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.